Inhibitor Therapeutics, Inc. (INTI) Total liabilities 2013–2021
Inhibitor Therapeutics, Inc. (INTI) total liabilities at each fiscal year-end, per SEC filings.
$3.7MFY2021 · since FY2013: $776,053 → $3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | $3.7M | +5.4% |
| FY2020 | $3.5M | +1.8% |
| FY2019 | $3.4M | +185.8% |
| FY2018 | $1.2M | +99.6% |
| FY2017 | $601,489 | +95.2% |
| FY2016 | $308,133 | -33.3% |
| FY2015 | $461,880 | +15.2% |
| FY2014 | $400,899 | -48.3% |
| FY2013 | $776,053 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice